<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03214120</url>
  </required_header>
  <id_info>
    <org_study_id>K5900405</org_study_id>
    <nct_id>NCT03214120</nct_id>
  </id_info>
  <brief_title>Does Modified Ultrafiltration Affect Thromboelastography Results?</brief_title>
  <official_title>Does Modified Ultrafiltration Affect Thromboelastography Results?</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Advocate Health Care</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Advocate Health Care</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study is to evaluate the effect of modified ultrafiltration on different components of
      Thromboelastography (TEG) in neonates undergoing cardiac surgery using cardiopulmonary
      bypass.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study will be performed at Advocate Children's Hospital, Oak Lawn. All neonates
      undergoing cardiac operations with cardiopulmonary bypass and modified ultrafiltration will
      be enrolled. Parents will be consented before surgery.

      After weaning from cardiopulmonary bypass and before starting modified ultrafiltration, a TEG
      sample will be taken. The components studied are Reaction time (R), Coagulation time (K),
      Angle, Maximum Amplitude (MA) and whole blood clot lysis index at 30 minutes (LY30). Another
      TEG sample will be taken after finishing modified ultrafiltration and before protamine is
      given. The different components will be compared pre and after modified ultrafiltration. The
      Primary end points are the changes of the different TEG components after modified
      ultrafiltration. The secondary end points are the utilization of different blood products
      (packed red cells, fresh frozen plasma and platelets transfusion) during and after surgery.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 8, 2018</start_date>
  <completion_date type="Anticipated">May 1, 2019</completion_date>
  <primary_completion_date type="Anticipated">January 1, 2019</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>2 Days</target_duration>
  <primary_outcome>
    <measure>change in thromboelastography components after modified ultrafiltration</measure>
    <time_frame>1 hour (time during surgery after doing modified ultrafiltration) to 2 days (postoperative recovery in intensive care unit)</time_frame>
    <description>effect of modified ultrafiltration on different components of thromboelastography</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>blood products utilization during and after surgery</measure>
    <time_frame>initial phase of recovery (2 days) in the intensive care unit after cardiac surgery</time_frame>
    <description>use of packed red cells, fresh frozen plasma and platelets during or after surgery</description>
  </secondary_outcome>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Congenital Heart Disease</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Neonates with congenital heart disease requiring cardiac surgery during the first month of
        life, with the use of cardiopulmonary bypass and modified ultrafiltration.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria: - neonates

          -  congenital heart disease

          -  pediatric cardiac operation with cardiopulmonary bypass

          -  modified ultrafiltration done at the end of cardiopulmonary bypass

        Exclusion Criteria: -patients older than 1 month.

          -  Cardiopulmonary bypass is not used

          -  Modified ultrafiltration is not performed
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>1 Month</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Chawki F Elzein, MD</last_name>
    <phone>7086833029</phone>
    <email>chawki.elzein@advocatehealth.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Advocate Children's Hospital</name>
      <address>
        <city>Oak Lawn</city>
        <state>Illinois</state>
        <zip>60453</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chawki Elzein, MD</last_name>
      <phone>708-684-3029</phone>
      <email>chawki.elzein@advocatehealth.com</email>
    </contact>
    <contact_backup>
      <last_name>Umair Abbas, MD</last_name>
      <phone>7086845580</phone>
      <email>Umair.abbas@advocatehealth.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Moat NE, Rebuck N, Shore DF, Evans TW, Finn AH. Humoral and cellular activation in a simulated extracorporeal circuit. Ann Thorac Surg. 1993 Dec;56(6):1509-14.</citation>
    <PMID>7505562</PMID>
  </results_reference>
  <results_reference>
    <citation>Luciani GB, Menon T, Vecchi B, Auriemma S, Mazzucco A. Modified ultrafiltration reduces morbidity after adult cardiac operations: a prospective, randomized clinical trial. Circulation. 2001 Sep 18;104(12 Suppl 1):I253-9.</citation>
    <PMID>11568065</PMID>
  </results_reference>
  <results_reference>
    <citation>Kane LC, Woodward CS, Husain SA, Frei-Jones MJ. Thromboelastography--does it impact blood component transfusion in pediatric heart surgery? J Surg Res. 2016 Jan;200(1):21-7. doi: 10.1016/j.jss.2015.07.011. Epub 2015 Jul 10.</citation>
    <PMID>26237992</PMID>
  </results_reference>
  <results_reference>
    <citation>Niebler RA, Gill JC, Brabant CP, Mitchell ME, Nugent M, Simpson P, Tweddell JS, Ghanayem NS. Thromboelastography in the assessment of bleeding following surgery for congenital heart disease. World J Pediatr Congenit Heart Surg. 2012 Oct 1;3(4):433-8. doi: 10.1177/2150135112447540.</citation>
    <PMID>23804904</PMID>
  </results_reference>
  <results_reference>
    <citation>Williams GD, Bratton SL, Riley EC, Ramamoorthy C. Coagulation tests during cardiopulmonary bypass correlate with blood loss in children undergoing cardiac surgery. J Cardiothorac Vasc Anesth. 1999 Aug;13(4):398-404.</citation>
    <PMID>10468251</PMID>
  </results_reference>
  <results_reference>
    <citation>Chew MS, Brandslund I, Brix-Christensen V, Ravn HB, Hjortdal VE, Pedersen J, Hjortdal K, Hansen OK, TÃ¸nnesen E. Tissue injury and the inflammatory response to pediatric cardiac surgery with cardiopulmonary bypass: a descriptive study. Anesthesiology. 2001 May;94(5):745-53; discussion 5A.</citation>
    <PMID>11388523</PMID>
  </results_reference>
  <results_reference>
    <citation>Paparella D, Yau TM, Young E. Cardiopulmonary bypass induced inflammation: pathophysiology and treatment. An update. Eur J Cardiothorac Surg. 2002 Feb;21(2):232-44. Review.</citation>
    <PMID>11825729</PMID>
  </results_reference>
  <results_reference>
    <citation>Bando K, Vijay P, Turrentine MW, Sharp TG, Means LJ, Ensing GJ, Lalone BJ, Sekine Y, Szekely L, Brown JW. Dilutional and modified ultrafiltration reduces pulmonary hypertension after operations for congenital heart disease: a prospective randomized study. J Thorac Cardiovasc Surg. 1998 Mar;115(3):517-25; discussion 525-7.</citation>
    <PMID>9535437</PMID>
  </results_reference>
  <results_reference>
    <citation>Huang H, Yao T, Wang W, Zhu D, Zhang W, Chen H, Fu W. Continuous ultrafiltration attenuates the pulmonary injury that follows open heart surgery with cardiopulmonary bypass. Ann Thorac Surg. 2003 Jul;76(1):136-40.</citation>
    <PMID>12842527</PMID>
  </results_reference>
  <results_reference>
    <citation>Forman KR, Wong E, Gallagher M, McCarter R, Luban NL, Massaro AN. Effect of temperature on thromboelastography and implications for clinical use in newborns undergoing therapeutic hypothermia. Pediatr Res. 2014 May;75(5):663-9. doi: 10.1038/pr.2014.19. Epub 2014 Feb 12.</citation>
    <PMID>24522100</PMID>
  </results_reference>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 4, 2017</study_first_submitted>
  <study_first_submitted_qc>July 7, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">July 11, 2017</study_first_posted>
  <last_update_submitted>March 8, 2018</last_update_submitted>
  <last_update_submitted_qc>March 8, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 12, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Advocate Health Care</investigator_affiliation>
    <investigator_full_name>Chawki Elzein</investigator_full_name>
    <investigator_title>Associate Clinical professor of Surgery</investigator_title>
  </responsible_party>
  <keyword>thromboelastography, modified ultrafiltration</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

